Author
Listed:
- Li-Jin Chan
(The Walter and Eliza Hall Institute of Medical Research
The University of Melbourne)
- Anugraha Gandhirajan
(Case Western Reserve University)
- Lenore L. Carias
(Case Western Reserve University)
- Melanie H. Dietrich
(The Walter and Eliza Hall Institute of Medical Research)
- Oscar Vadas
(University of Geneva
University of Geneva)
- Remy Visentin
(University of Geneva
University of Geneva)
- Camila T. França
(The Walter and Eliza Hall Institute of Medical Research
The University of Melbourne)
- Sebastien Menant
(The Walter and Eliza Hall Institute of Medical Research)
- Dominique Soldati-Favre
(University of Geneva)
- Ivo Mueller
(The Walter and Eliza Hall Institute of Medical Research
The University of Melbourne)
- Christopher L. King
(Case Western Reserve University
Veteran Affairs Research Service, VA Medical Center)
- Wai-Hong Tham
(The Walter and Eliza Hall Institute of Medical Research
The University of Melbourne)
Abstract
Plasmodium vivax preferentially invades reticulocytes and recognition of these cells is mediated by P. vivax Reticulocyte Binding Protein 2b (PvRBP2b) binding to human Transferrin receptor 1 (TfR1) and Transferrin (Tf). Longitudinal cohort studies in Papua New Guinea, Thailand and Brazil show that PvRBP2b antibodies are correlated with protection against P. vivax infection and disease. Here, we isolate and characterize anti-PvRBP2b human monoclonal antibodies from two individuals in Cambodia with natural P. vivax infection. These antibodies bind with high affinities and map to different regions of PvRBP2b. Several human antibodies block PvRBP2b binding to reticulocytes and inhibit complex formation with human TfR1-Tf. We describe different structural mechanisms for functional inhibition, including either steric hindrance with TfR1-Tf or the reticulocyte membrane. These results show that naturally acquired human antibodies against PvRBP2b can inhibit its function which is important for P. vivax invasion.
Suggested Citation
Li-Jin Chan & Anugraha Gandhirajan & Lenore L. Carias & Melanie H. Dietrich & Oscar Vadas & Remy Visentin & Camila T. França & Sebastien Menant & Dominique Soldati-Favre & Ivo Mueller & Christopher L., 2021.
"Naturally acquired blocking human monoclonal antibodies to Plasmodium vivax reticulocyte binding protein 2b,"
Nature Communications, Nature, vol. 12(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-21811-2
DOI: 10.1038/s41467-021-21811-2
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-21811-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.